To evaluate the diagnostic performance of the IOTA-models Simple Rules and logistic regression models LR1 and LR2 in adnexal masses. Methods: Retrospective data analysis of 291 women with adnexal masses examined with transvaginal ultrasound by one expert sonographer from 2009 to 2015. Sonographic data was applied to the IOTA-Models Simple Rules, LR1 and LR2 in order to distinguish benign from malignant adnexal masses. All examined women underwent subsequent surgical removal and histological diagnosis of adnexal mass was available in all cases. Results: Of 291 patients with an adnexal mass, 263 (90,4%) had histologically benign and 28 (9,6%) had malignant tumours. The Simple Rules resulted in a specificity of 96,8% (95%CI, 94,5 -99,1) and sensitivity of 100,0% (95%CI, 100,0). LR1 resulted in a specificity of 94% (95%CI, 90,2) and sensitivity of 100,0% (95%CI, 100,0). LR2 resulted in a specificity of 95,9% (95%CI, 93,1-99,0) and sensitivity of 100,0% (95%CI, 100,0). The negative predictive value (NPV) was 100,0% (95%CI, 100,0) for Simple Rules, LR1 and LR2. The positive predictive value (PPV) was 65,0% (95%CI, 58,9-71,1) for Simple Rules, 65,8% (95%CI, 59,8) for LR1 and 74,2% (95%CI, 68,4-80,0) for LR2. Conclusions: Results of this study show a high number of patients with histologically benign adnexal masses, which were retrospectively also classified as benign by IOTA models (NPV 100%). The application of IOTA models may support sonographers in the decision-making process of management of patients with adnexal masses and may avoid unnecessary surgical intervention. All histologically malignant tumours were identified as malignant by the three IOTA models (Sensitivity 100%). However, due to the small sample size of 28 malignant adnexal masses in our study, results need to be cautiously interpreted. Methods: Secondary analysis on IOTA phase 3, an international multicentre study, involving 2368 patients recruited between 2009 and 2012. All patients had at least one adnexal mass and underwent a standardised transvaginal ultrasound examination before being selected for surgery. Gold standard was the postoperative histopathology of the adnexal lesion. When revised benign EDs could not be applied as first step, diagnostic performances of RMI,
Objectives: Ovarian cancer is a silent killer, metastasising throughout the abdomen before causing symptoms. So far, research concerning the immune system in ovarian cancer has focussed on the intratumoral immune changes. The peripheral immune landscape in ovarian cancer remains largely undiscovered. Methods: In 39 patients with invasive ovarian cancer, blood was taken at diagnosis. Simultaneously, a tumour biopsy from the primary tumour and/or metastasis was prelevated in 31 of them. Activated CD8 + T cells (CD8 + CD69 + ) were measured in blood, 
